-
Je něco špatně v tomto záznamu ?
The relationship between ECG predictors of cardiac resynchronization therapy benefit
J. Halamek, P. Leinveber, I. Viscor, R. Smisek, F. Plesinger, V. Vondra, J. Lipoldova, M. Matejkova, P. Jurak,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
Public Library of Science (PLoS)
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-12-01
Open Access Digital Library
od 2006-10-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-12-01
Health & Medicine (ProQuest)
od 2006-12-01
Public Health Database (ProQuest)
od 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
- MeSH
- akční potenciály MeSH
- blokáda Tawarova raménka patofyziologie terapie MeSH
- elektrická defibrilace MeSH
- elektrokardiografie metody normy MeSH
- funkce levé komory srdeční MeSH
- lidé MeSH
- prediktivní hodnota testů MeSH
- prostředky srdeční resynchronizační terapie normy MeSH
- srdeční frekvence MeSH
- srdeční resynchronizační terapie metody MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
INTRODUCTION: Cardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality and improves cardiac function in patients with left bundle branch block (LBBB). However, about 30% of patients passing the current criteria do not benefit or benefit only a little from CRT. Three predictors of benefit based on different ECG properties were compared: 1) "strict" left bundle branch block classification (SLBBB); 2) QRS area; 3) ventricular electrical delay (VED) which defines the septal-lateral conduction delay. These predictors have never been analyzed concurrently. We analyzed the relationship between them on a subset of 602 records from the MADIT-CRT trial. METHODS & RESULTS: SLBBB classification was performed by two experts; QRS area and VED were computed fully automatically. High-frequency QRS (HFQRS) maps were used to inspect conduction abnormalities. The correlation between SLBBB and other predictors was R = 0.613, 0.523 and 0.390 for VED, QRS area in Z lead, and QRS duration, respectively. Scatter plots were used to pick up disagreement between the predictors. The majority of SLBBB subjects- 295 of 330 (89%)-are supposed to respond positively to CRT according to the VED and QRS area, though 93 of 272 (34%) non-SLBBB should also benefit from CRT according to the VED and QRS area. CONCLUSION: SLBBB classification is limited by the proper setting of cut-off values. In addition, it is too "strict" and excludes patients that may benefit from CRT therapy. QRS area and VED are clearly defined parameters. They may be used to optimize biventricular stimulation. Detailed analysis of conduction irregularities with CRT optimization should be based on HFQRS maps.
Institute of Scientific Instruments of the Czech Academy of Sciences Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006303
- 003
- CZ-PrNML
- 005
- 20200518132528.0
- 007
- ta
- 008
- 200511s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0217097 $2 doi
- 035 __
- $a (PubMed)31150418
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Halamek, Josef $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 245 14
- $a The relationship between ECG predictors of cardiac resynchronization therapy benefit / $c J. Halamek, P. Leinveber, I. Viscor, R. Smisek, F. Plesinger, V. Vondra, J. Lipoldova, M. Matejkova, P. Jurak,
- 520 9_
- $a INTRODUCTION: Cardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality and improves cardiac function in patients with left bundle branch block (LBBB). However, about 30% of patients passing the current criteria do not benefit or benefit only a little from CRT. Three predictors of benefit based on different ECG properties were compared: 1) "strict" left bundle branch block classification (SLBBB); 2) QRS area; 3) ventricular electrical delay (VED) which defines the septal-lateral conduction delay. These predictors have never been analyzed concurrently. We analyzed the relationship between them on a subset of 602 records from the MADIT-CRT trial. METHODS & RESULTS: SLBBB classification was performed by two experts; QRS area and VED were computed fully automatically. High-frequency QRS (HFQRS) maps were used to inspect conduction abnormalities. The correlation between SLBBB and other predictors was R = 0.613, 0.523 and 0.390 for VED, QRS area in Z lead, and QRS duration, respectively. Scatter plots were used to pick up disagreement between the predictors. The majority of SLBBB subjects- 295 of 330 (89%)-are supposed to respond positively to CRT according to the VED and QRS area, though 93 of 272 (34%) non-SLBBB should also benefit from CRT according to the VED and QRS area. CONCLUSION: SLBBB classification is limited by the proper setting of cut-off values. In addition, it is too "strict" and excludes patients that may benefit from CRT therapy. QRS area and VED are clearly defined parameters. They may be used to optimize biventricular stimulation. Detailed analysis of conduction irregularities with CRT optimization should be based on HFQRS maps.
- 650 _2
- $a akční potenciály $7 D000200
- 650 _2
- $a blokáda Tawarova raménka $x patofyziologie $x terapie $7 D002037
- 650 _2
- $a srdeční resynchronizační terapie $x metody $7 D058406
- 650 _2
- $a prostředky srdeční resynchronizační terapie $x normy $7 D058409
- 650 _2
- $a elektrická defibrilace $7 D004554
- 650 _2
- $a elektrokardiografie $x metody $x normy $7 D004562
- 650 _2
- $a srdeční frekvence $7 D006339
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a funkce levé komory srdeční $7 D016277
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Leinveber, Pavel $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Viscor, Ivo $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Smisek, Radovan $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Plesinger, Filip $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Vondra, Vlastimil $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Lipoldova, Jolana $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Matejkova, Magdalena $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Jurak, Pavel $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 14, č. 5 (2019), s. e0217097
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31150418 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132527 $b ABA008
- 999 __
- $a ok $b bmc $g 1525161 $s 1096359
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 14 $c 5 $d e0217097 $e 20190531 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20200511